These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
680 related articles for article (PubMed ID: 19854938)
41. Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides. Lee LK; Williams CL; Devore D; Roth CM Biomacromolecules; 2006 May; 7(5):1502-8. PubMed ID: 16677032 [TBL] [Abstract][Full Text] [Related]
42. Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi. Bilanges B; Stokoe D Biochem J; 2005 Jun; 388(Pt 2):573-83. PubMed ID: 15656792 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo. Mook OR; Baas F; de Wissel MB; Fluiter K Mol Cancer Ther; 2007 Mar; 6(3):833-43. PubMed ID: 17363479 [TBL] [Abstract][Full Text] [Related]
45. Lipid-modified oligonucleotide conjugates: Insights into gene silencing, interaction with model membranes and cellular uptake mechanisms. Ugarte-Uribe B; Grijalvo S; Pertíñez SN; Busto JV; Martín C; Alagia A; Goñi FM; Eritja R; Alkorta I Bioorg Med Chem; 2017 Jan; 25(1):175-186. PubMed ID: 27810441 [TBL] [Abstract][Full Text] [Related]
46. Self-Assembled Double-Bundle DNA Tetrahedron for Efficient Antisense Delivery. Yang J; Jiang Q; He L; Zhan P; Liu Q; Liu S; Fu M; Liu J; Li C; Ding B ACS Appl Mater Interfaces; 2018 Jul; 10(28):23693-23699. PubMed ID: 29963858 [TBL] [Abstract][Full Text] [Related]
47. Antisense locked nucleic acids efficiently suppress BCR/ABL and induce cell growth decline and apoptosis in leukemic cells. Rapozzi V; Cogoi S; Xodo LE Mol Cancer Ther; 2006 Jul; 5(7):1683-92. PubMed ID: 16891454 [TBL] [Abstract][Full Text] [Related]
48. Locked nucleic acid antisense inhibitor targeting apolipoprotein C-III efficiently and preferentially removes triglyceride from large very low-density lipoprotein particles in murine plasma. Yamamoto T; Obika S; Nakatani M; Yasuhara H; Wada F; Shibata E; Shibata MA; Harada-Shiba M Eur J Pharmacol; 2014 Jan; 723():353-9. PubMed ID: 24269597 [TBL] [Abstract][Full Text] [Related]
49. Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer. Cheng X; Liu Q; Li H; Kang C; Liu Y; Guo T; Shang K; Yan C; Cheng G; Lee RJ Pharm Res; 2017 Feb; 34(2):310-320. PubMed ID: 27896589 [TBL] [Abstract][Full Text] [Related]
50. A hyaluronic acid-based hydrogel enabling CD44-mediated chondrocyte binding and gapmer oligonucleotide release for modulation of gene expression in osteoarthritis. Cai Y; López-Ruiz E; Wengel J; Creemers LB; Howard KA J Control Release; 2017 May; 253():153-159. PubMed ID: 28274742 [TBL] [Abstract][Full Text] [Related]
51. Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA. Beisner J; Dong M; Taetz S; Piotrowska K; Kleideiter E; Friedel G; Schaefer U; Lehr CM; Klotz U; Mürdter TE J Pharm Sci; 2009 May; 98(5):1765-74. PubMed ID: 18803262 [TBL] [Abstract][Full Text] [Related]
52. Downregulation of p21(WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA). Jepsen JS; Pfundheller HM; Lykkesfeldt AE Oligonucleotides; 2004; 14(2):147-56. PubMed ID: 15294077 [TBL] [Abstract][Full Text] [Related]
53. [Effect of phosphorothioate antisense Bcl-xL oligodeoxynucleotides on apoptosis and thermosensitivity of BcaCD885 cells]. He YW; Bian L; Liang XH Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):112-4. PubMed ID: 15190790 [TBL] [Abstract][Full Text] [Related]
56. Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptake. Axel DI; Spyridopoulos I; Riessen R; Runge H; Viebahn R; Karsch KR J Vasc Res; 2000; 37(4):221-34; discussion 303-4. PubMed ID: 10965222 [TBL] [Abstract][Full Text] [Related]
57. Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro. Raguraman P; Wang T; Ma L; Jørgensen PT; Wengel J; Veedu RN Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244535 [TBL] [Abstract][Full Text] [Related]
58. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187 [TBL] [Abstract][Full Text] [Related]
59. Is there a future for cell-penetrating peptides in oligonucleotide delivery? Lee SH; Castagner B; Leroux JC Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313 [TBL] [Abstract][Full Text] [Related]
60. Calcium-Mediated In Vitro Transfection Technique of Oligonucleotides with Broad Chemical Modification Compatibility. Wada F; Hori SI; Obika S; Yamamoto T Methods Mol Biol; 2020; 2176():141-154. PubMed ID: 32865788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]